269 related articles for article (PubMed ID: 8482433)
21. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.
Frontoni S; Choi SB; Banduch D; Rossetti L
Diabetes; 1991 May; 40(5):568-73. PubMed ID: 2022302
[TBL] [Abstract][Full Text] [Related]
22. Non-esterified fatty acids regulate lipid and glucose oxidation and glycogen synthesis in healthy man.
Ebeling P; Koivisto VA
Diabetologia; 1994 Feb; 37(2):202-9. PubMed ID: 8163056
[TBL] [Abstract][Full Text] [Related]
23. Relative contribution of glycogen synthesis and glycolysis to insulin-mediated glucose uptake. A dose-response euglycemic clamp study in normal and diabetic rats.
Rossetti L; Giaccari A
J Clin Invest; 1990 Jun; 85(6):1785-92. PubMed ID: 2189891
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of insulin action in muscle: influence of blood flow.
James DE; Burleigh KM; Storlien LH; Bennett SP; Kraegen EW
Am J Physiol; 1986 Oct; 251(4 Pt 1):E422-30. PubMed ID: 3532818
[TBL] [Abstract][Full Text] [Related]
25. Prior eccentric contractions impair maximal insulin action on muscle glucose uptake in the conscious rat.
Asp S; Watkinson A; Oakes ND; Kraegen EW
J Appl Physiol (1985); 1997 Apr; 82(4):1327-32. PubMed ID: 9104872
[TBL] [Abstract][Full Text] [Related]
26. Dichloroacetate inhibits glycolysis and augments insulin-stimulated glycogen synthesis in rat muscle.
Clark AS; Mitch WE; Goodman MN; Fagan JM; Goheer MA; Curnow RT
J Clin Invest; 1987 Feb; 79(2):588-94. PubMed ID: 3543056
[TBL] [Abstract][Full Text] [Related]
27. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
[TBL] [Abstract][Full Text] [Related]
28. Metabolic control analysis of insulin-stimulated glucose disposal in rat skeletal muscle.
Jucker BM; Barucci N; Shulman GI
Am J Physiol; 1999 Sep; 277(3):E505-12. PubMed ID: 10484363
[TBL] [Abstract][Full Text] [Related]
29. Intracellular pathways of insulin-mediated glucose uptake before and after puberty in conscious rats.
Raghavan S; Saenger P; Hu M; Barzilai N
Pediatr Res; 1997 Mar; 41(3):340-5. PubMed ID: 9078532
[TBL] [Abstract][Full Text] [Related]
30. Time course of insulin action on tissue-specific intracellular glucose metabolism in normal rats.
Koopmans SJ; Mandarino L; DeFronzo RA
Am J Physiol; 1998 Apr; 274(4):E642-50. PubMed ID: 9575825
[TBL] [Abstract][Full Text] [Related]
31. Effects of placental lactogen and progesterone on insulin stimulated glucose metabolism in rat muscles in vitro.
Leturque A; Hauguel S; Sutter Dub MT; Maulard P; Girard J
Diabete Metab; 1989; 15(4):176-81. PubMed ID: 2680668
[TBL] [Abstract][Full Text] [Related]
32. Effect of impaired glucose uptake on postexercise glycogen repletion in skeletal muscles of insulin-treated streptozotocin-diabetic fasted rats.
Ferreira LD; Xu D; Palmer TN; Fournier PA
Metabolism; 2005 Nov; 54(11):1420-7. PubMed ID: 16253628
[TBL] [Abstract][Full Text] [Related]
33. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo.
Choi SB; Frontoni S; Rossetti L
Am J Physiol; 1991 Feb; 260(2 Pt 1):E321-5. PubMed ID: 1996634
[TBL] [Abstract][Full Text] [Related]
34. Modulation by adrenalectomy and fasting of insulin effects in perfused hindlimb muscle.
Shikama H; Chu DT; Exton JH
Am J Physiol; 1982 May; 242(5):E323-9. PubMed ID: 6805333
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of lipoic acid stereoisomers on glucose metabolism in insulin-resistant skeletal muscle.
Streeper RS; Henriksen EJ; Jacob S; Hokama JY; Fogt DL; Tritschler HJ
Am J Physiol; 1997 Jul; 273(1 Pt 1):E185-91. PubMed ID: 9252495
[TBL] [Abstract][Full Text] [Related]
36. Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding.
Oakes ND; Cooney GJ; Camilleri S; Chisholm DJ; Kraegen EW
Diabetes; 1997 Nov; 46(11):1768-74. PubMed ID: 9356024
[TBL] [Abstract][Full Text] [Related]
37. Effects of blockade of fatty acid oxidation on whole body and tissue-specific glucose metabolism in rats.
Jenkins AB; Storlien LH; Cooney GJ; Denyer GS; Caterson ID; Kraegen EW
Am J Physiol; 1993 Oct; 265(4 Pt 1):E592-600. PubMed ID: 8238335
[TBL] [Abstract][Full Text] [Related]
38. Studies on the effects of growth hormone administration in vivo on the rates of glucose transport and utilization in rat skeletal muscle.
Dimitriadis G; Parry-Billings M; Leighton B; Piva T; Dunger D; Calder P; Bond J; Newsholme E
Eur J Clin Invest; 1994 Mar; 24(3):161-5. PubMed ID: 8033949
[TBL] [Abstract][Full Text] [Related]
39. A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Oakes ND; Kennedy CJ; Jenkins AB; Laybutt DR; Chisholm DJ; Kraegen EW
Diabetes; 1994 Oct; 43(10):1203-10. PubMed ID: 7926289
[TBL] [Abstract][Full Text] [Related]
40. Hyperglycemia markedly enhances skeletal muscle glycogen synthase activity in diabetic, but not in normal conscious rats.
Farrace S; Rossetti L
Diabetes; 1992 Nov; 41(11):1453-63. PubMed ID: 1397721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
